Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Kidney Failure, Chronic

• CAR-T Cell Therapy for Desensitization in Kidney Transplantation
• DIALYSIS-TIR Study
• Impact of Dapagliflozin on Intestinal Microbiota Composition and on the Metabolites Derived From the Intestinal Microbiota in Non-diabetic Chronic Renal Failure Patients
• A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease
• CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
• Pharmacokinetics of Intravenous Difelikefalin in Chinese Adult Subjects on Haemodialysis
• A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Ch
• Carry Life@ UF System Clinical Study
• PTH Attenuation Trial in Hemodialysis-2
• Impact of Hemodialysis on Plasma Carnitine Levels in Patients With End Stage Renal Disease
• Efficacy of L-methylfolate and Methylcobalamine in Treating Hypertension and Its Impact on Serum Homocysteine in Hemodialysis Patients With Resistant Hypertension
• Safety and Efficacy of Empagliflozin in Hemodialysis
• Single Dose Study of MK-2060 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Older Japanese Participants on Dialysis (MK-2060-012)
• The Effect of Intravenous Iron Therapy and Erythropoiesis-stimulation Agent Combination on Renal Transplant Outcomes
• meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis
• Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis
• Empagliflozin in ESKD - A Feasibility Study
• DApagliflozin Cardiovascular Effects on Patients at End-stage REnal Disease
• Colchicine and Inflammation in Hemodialysis Patients
• Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease
• A Study of MK-2060 in Participants With Chronic Kidney Disease (MK-2060-011)
• Effects of Shenkang Decoction on Creatinine and Blood Urea Nitrogen in Chronic Renal Failure Hemodialysis Patients
• Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD
• Belatacept as a Replacement for CNIs 3 to 12 Months Post-transplantation in Patients With Early Graft Dysfunction
• Oral Iron Supplementation for Patients With Chronic Kidney Disease
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
• A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery
• CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease
• One-month Latent Tuberculosis Treatment for Renal Transplant Candidates
• Chronic Anticoagulation With a Reduced Dose Regimen of Rivaroxaban in End-stage Renal Disease Patients
• The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis
• Novel Desensitization Protocol for Highly Sensitized Patients to Allow for Successful Kidney Transplantation. A Pilot Study.
• Pharmacokinetics and Dialyzability of Dapagliflozin in Dialysis Patients
• MK-2060 and Clopidogrel Co-administration Safety and Tolerability Study in Participants With End-Stage Renal Disease (ESRD) (MK-2060-008)
• Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation
• A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD)
• A Novel Role of Alpha Lipoic Acid in Comparison With Selenium in Mitochondrial Resuscitation and miRNA-126 Expression in Hemodialysis Patients
• Reduction of Peritoneal Glucose Uptake With Use of SGLT2 in Humans Undergoing Peritoneal Dialysis Treatment
• The POWERED Study: Prophylaxis With Metformin to Prevent PTDM
• AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNce
• Phase III Clinical Study of Recombinant Erythropoiesis Stimulating Protein Injection (rESP) in the Treatment of Anemia in Hemodialysis Patients With Chronic Renal Failure
• Icodextrin Study to Test Short-Term Safety, Tolerability and Preliminary Efficacy of Sodium-Free Solution in PD Patients
• DIalysis Symptom COntrol-Pruritus Outcome Trial
• The Home Blood Pressure (BP) Trial
• The Danish Pre-HCQ COVID Dialysis Study
• Furosemide and Creatinine Tubular Stress Test in Order to Measure Proximal Tubule Residual Function
• To Assess the Pharmacokinetics, Safety, and Tolerability of AZD8233 in Participants With Chronic Kidney Disease (CKD), End Stage Renal Disease (ESRD) and Healthy Participants.
• Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (Factor XI Hemodialysis Study) (MK-2060-007)
• Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney Disease
• A Study of Belzutifan (MK-6482) in Participants With Renal Impairment (MK-6482-021)
• Comparison of Serum Calcium Level Between Preoperative Vitamin D and Non-vitamin D Regimen of Total Parathyroidectomy in End-stage Renal Failure Patients in Rajavithi Hospital
• Evaluation of The Effect of Rutin and Vitamin C on the Oxidative Stress in Hemodialysis Patients
• Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers
• Methadone Anesthesia For Kidney Transplant Receptors
• PK Study of IV and Oral Amisulpride in Subjects With Severe Renal Impairment
• Pharmacokinetics in End Stage Renal Disease Patients
• Dapagliflozin Effect on Cardiovascular Outcomes in Haemodialysis for End Stage Renal Disease
• Plazomicin Study in ESRD Patients Receiving IHD
• Berinert (C1INH) vs Placebo for DGF/IRI
• Triferic AVNU Infusion Via Freedom Pump During Hemodialysis
• Removal of Doravirine by Hemodialysis in HIV-Infected Patients With End-stage Renal Disease (ESRD)
• Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney Transplant
• Efficacy of Corticosteroids in Reducing the Renal Scarring in Acute Pyelonephritis in Children
• Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan.
• Single Patient Protocol for Donor HCV-positive to Recipient HCV-negative Kidney Transplant in a Patient at Risk for Loss of Dialysis Access
• Safety & Efficacy of DCR-PHXC in Patients With PH1/2 and ESRD
• Kidney Transplants in Hepatitis C Negative Recipients With Hepatitis C Viremic Donors
• HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis
• Efficacy of Diuretics in Kidney Disease
• Docohexanoic Acid in Hemodialysis Patients
• Factor XI LICA to Reduce Events Such as Heart Attack and Stroke in Patients Whose Kidneys Are no Longer Able to Work as They Should and Require Treatment to Filter Wastes From the Blood: Focus is on the Safety of BAY2976217 and the Way the Body Abso
• Iron Therapy in Patients With End-Stage Renal Disease
• Study of Roxadustat Conversion in Subjects Receiving Stable ESA or as Initial Anemia Treatment in Hemodialysis Patients
• Comparative Study Evaluating the Effect of Vitamin K1 Versus Vitamin K2 on Vascular Calcification in Dialysis Patients
• Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis
• Study of Roxadustat Conversion in Subjects Receiving Stable ESA or as Initial Anemia Treatment in Chronic Dialysis Patients
• Study to Investigate the Pharmacokinetic Comparability of Dosing Triferic AVNU IV by Continuous Infusion and IV Bolus.
• AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses
• The Modification of Diet in Renal Disease Study
• Evaluation of Thiosulfate in End Stage Renal Disease and Kidney Transplantation
• Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)
• A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis
• Pilot Study: Interest of Belatacept as a Non-nephrotoxic Immunosuppressive Treatment in Cardiac Transplant Patients at Risk of Chronic Renal Failure (BELACOEUR)
• Effect of Vitamin K 2 on Vascular Calcification in Hemodialysis Patients
• The Effect of Intradialytic Parenteral Nutrition on Nutritional Status and Quality of Life in Hemodialysis Patients
• Ultrafiltration Efficacy of a PD Solution Containing Icodextrin-Xylitol-Carnitine
• Effect of Amlodipine Versus Bisoprolol on Hypertensive Patients With End-stage Renal Disease on Maintenance Hemodialysis.
• A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients
• A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)
• Bicarbonate vs Heparin Catheter Lock in Chronic Hemodialysis Patients
• A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients
• CNI Transient Replacement by Belatacept From 3 to 12 Months Post Transplantation in Patients With Early Graft Dysfunction
• Desidustat in the Treatment of Anemia in CKD
• Apixaban in Subjects With Peritoneal Dialysis
• Efficacy and Safety Assessments of a Peritoneal Dialysis Solution Containing Glucose, Xylitol, and L-Carnitine in CAPD
• Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.
• A Long-Term Study to Evaluate the Ability of Tenapanor Alone or in Combination With Sevelamer to Treat to Goal Serum Phosphorus in Patients With End-Stage Kidney Disease on Dialysis
• Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis
• Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis
• Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease
• Safety and Efficacy Study of AB002 (E-WE Thrombin) in End Stage Renal Disease Patients on Chronic Hemodialysis
• Effect of Add-on Spironolactone to Losartan Versus Losartan Alone on Peritoneal Membrane Among Peritoneal Dialysis Patients
• Study of rESP Injection for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis
• Study to Evaluate the Pharmacokinetics and Metabolism of [14C] CR845 (Difelikefalin) in Patients With End Stage Renal Disease on Hemodialysis and in Healthy Subjects
• A Study of Orally Administered Pimodivir in Adult Participants With Renal Impairment
• HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing Hemodialysis
• Tobramycin Administered at the Beginning of Dialysis
• Safety of Sofosbuvir in People With Advanced Kidney Failure
• Safety and Pharmacokinetics of MK-2060 in Older Participants With End-Stage Renal Disease on Hemodialysis (MK-2060-004)
• The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
• Better Evidence for Selecting Transplant Fluids
• Plasma Amino Acid Levels After Protein Ingestion or Amino Acid Injection During Dialysis
• DIalysis Symptom COntrol-Restless Legs Syndrome Trial
• A Study to Investigate the Influence of PTH-lowering by Etelcalcetide (Parsabiv®) on the Calcification Propensity of Serum in Dialysis Patients
• End-stage Renal Disease (ESRD) Pilot Study
• Multi-center Study to Transplant Hepatitis-C Infected Kidneys
• Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients
• A Pilot Trial of Twice-weekly Versus Thrice-weekly Hemodialysis in Patients With Incident End-stage Kidney Disease
• Effects of Empagliflozin on Endogenous Glucose Production in End Stage Renal Disease(ESRD).
• Effect of Vitamin D Supplementation on Balance in CKD
• Effectiveness of Ropinirole and Gabapentin for the Treatment of RLS in Patients on Maintenance HD
• Predictors of Response to Iron and Erythropoietin Stimulating Agents
• Glucose Disorders Induced by Tacrolimus on Pre Transplantation Endstage Renal Disease Patients
• Serum Ceftazidime Concentrations in Hemodialysis Patients
• Outcomes of the Use of Sodium Bicarbonate (8.4%) Solution as a Catheter Lock Solution to Prevent Hemodialysis Catheter Loss Due to Lumen Clot Formation
• Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors
• Safety and Efficacy Study of AB023 (Xisomab 3G3) in End Stage Renal Disease Patients on Chronic Hemodialysis
• Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI
• Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
• A Study to Evaluate JNJ-64565111 Pharmacokinetics and Safety in Adult Participants With Varying Degrees of Renal Function
• Short and Long-Term Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis
• Pilot: Insulin Sensitivity/Management in Hyperglycemic Patients in Perioperative Period ESRD/Non-ESRD
• Evaluation of Desensitization Protocols in HLA-incompatible Kidney-transplant Candidates
• Ombitasvir/ Paritaprevir / Ritonavir Plus Ribavirin in Management HCV and End-stage Kidney Disease
• A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney Function
• Sodium Chloride and Contrast Nephropathy
• Blood Pressure Lowering in Dialysis (BOLD) Trial
• Apixaban in End-stage Kidney Disease : A Pharmacokinetics Study
• The Effect of an Antibiotic on the Production of Uremic Toxins by the Gut Microbiome
• the Effect of Calcium Dobesilate on Non Dialysis Patients With CKD
• Effect of Hyperuricaemia on Chronic Renal Disease
• Comparing Efficacy and Safety of CinnaGen Beta Erythropoietin (CinnaPoietin®) Versus Eprex® on the Treatment of Anemia in ESRD Hemodialysis Patients
• Clinical Trial to eLiminate HCV-infection in Treatment-naïve, Renally Impaired EgyptiAn Patients on Renal Dialysis, With Chronic Hepatitis C Genotype 4
• Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant
• A Study of ISIS 416858 Administered Subcutaneously to Participants With End-Stage Renal Disease (ESRD) on Hemodialysis
• The Effects of Patiromer on Serum Potassium Level and Gut Microbiome of ESRD Patients With Hyperkalemia
• Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease
• Treatment of Chronic Renal Failure With Adipose Tissue-derived Mesenchymal Stem Cells
• Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
• The Feasibility of Propofol TCI in Hemodialysis Patients Undergoing Arteriovenous Shunt Surgery
• Equivalence of Triferic® (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients
• Extended Release Tacrolimus vs. Twice-Daily Tacrolimus
• A Pilot Study Using Autologous Regulatory T Cell Infusion Zortress (Everolimus) in Renal Transplant Recipients
• Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis
• Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial
• Ixazomib for Desensitization
• Trial to Evaluate Safety and Tolerability of Tacrolimus Extended-Release (Astagraf XL) in HLA Sensitized Kidney Transplant Recipients
• A Two-Part Phase 2a Study of RVX000222 in Patients With End-Stage Renal Disease Treated With Hemodialysis
• Traditional Chinese Medicine (TCM) Colon Dialysis Treats Non-dialysis End-Stage Kidney Disease
• Anti-Cytokine Therapy for Hemodialysis InflammatION
• A Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney Transplant
• Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney Transplant
• Treating Hepatitis C in CRF Using Sofosbuvir and Daclatasvir
• Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease
• Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With Advanced Chronic Kidney Disease
• Ferric Citrate in ESRD Pilot Project
• Sofosbuvir/Velpatasvir in Adults With Chronic Hepatitis C Virus Infection Who Are on Dialysis for End Stage Renal Disease
• Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal Disease
• Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease
• Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj.
• The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum
• A Study to Evaluate Safety of Single Doses of BMS-986177 in Patients With End Stage Renal Disease (ESRD) Treated With Hemodialysis
• Effect of SNF472 on Progression of Cardiovascular Calcification in End-Stage-Renal-Disease (ESRD) Patients on Hemodialysis (HD)
• LMWH Infusion as Anticoagulation for Home HD
• Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
• Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD)
• Relypsa For ED Acute Hyperkalemia Control and Reduction (REDUCE)
• Effectiveness of Probiotics to Treat End Stage Renal Disease
• A Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunction on Chronic Stable Hemodialysis Treatment
• Oral Anticoagulation in Haemodialysis Patients
• Study in End-stage Renal Disease Patients Awaiting Kidney Transplant to Investigate the Potential Effect of IVIG Treatment on the Pharmacokinetics and Pharmacodynamics of LFG316
• Effect of Febuxostat on Endothelial Dysfunction in Hemodialysis Patients.
• Acute Pharmacokinetic-pharmacodynamic Change of Rocuronium After Reperfusion of Renal Graft
• Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure
• HELPS Study - A Study of Peginterferon Alfa-2a (Pegasys) in Patients With Chronic Hepatitis C (CHC) and End-Stage Renal Disease (ESRD)
• Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD)
• Mass Balance Study of JTZ-951 in Subjects With End-stage Renal Disease on Hemodialysis
• A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test
• Exploring Renal Transplants Using Hepatitis C Infected Donors for HCV-negative Recipients
• Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients
• Pharmacokinetics and Preliminary Bioequivalence of Triferic (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients
• Impact of Rifaximin Therapy on Intestinal Byproducts in End-Stage Renal Disease
• The Impact of Early Protocol Biopsy in Kidney Transplant
• Creation of Arteriovenous Ante-brachial Fistula Under Axillary Block Versus Local Anesthesia : Impact on Early Complications
• Sup-Icu RENal (SIREN)
• Treatment of Uremic Pruritus With PA101B
• Reduction of Plasma Free VEGF-A Using Low-dose Bevacizumab in Hemodialysis Patients
• Effects of Oral Sodium Bicarbonate Supplementation in Haemodialysis Patients (BicHD)
• Phase Ⅳ Clinical Trial to Evaluate of Renamezin in Patients With Chronic Renal Failure.
• A Multicenter, Randomized, Open-labeled, Cross-over, Active-controlled, Phase IV Clinical Trial to Evaluate the Preference of Formulation and the Efficacy and Safety of Renamezin and Kremezin in Pre-dialysis Patients With Chronic Renal Failure
• An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
• A Study of the Pharmacokinetics and Safety of BMS-663068 Administered in Subjects With Normal Renal Function and With Mild, Moderate, Severe and End Stage Renal Dysfunction (ESRD)
• Apixaban in Hemodialysis
• Evaluating the Effect of Fumaria Parviflora L. in Uremic Pruritus
• The Effect of Steroid Pulse Therapy for the Reduction of Acute Rejection Episode in Subclinical Borderline Changes
• A Study of Ferric Citrate to Improve Inflammation and Lipid Levels
• Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection
• Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Intravenously to Healthy Adult Volunteers
• A Multiple-Dose Study of Oral Oseltamivir in Participants on Hemodialysis (HD) and Continuous Ambulatory Peritoneal Dialysis (CAPD)
• Effects of Cholecalciferol on Osteoprotegerin Levels in Patients on Peritoneal Dialysis
• Triferic Pediatric Pharmacokinetic Protocol
• Effect of Sodium Rinsing Fluid on Blood Pressure and Interdialytic Weight Change in Hemodialysis Patients
• Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis
• A Study of Obinutuzumab to Evaluate Safety and Tolerability in Hypersensitized Adult Participants With End Stage Renal Disease Awaiting Transplantation
• Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease
• The Safety and Efficacy of Daclatasvir and Asunaprevir With Chronic HCV Genotype 1b Infection and Chronic Renal Failure
• A Study of Safety, PK, & PD of ISIS 416858 Administered Subcutaneously to Patients With End-Stage Renal Disease on Hemodialysis
• Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes
• A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Dis
• Renal Hemodynamic Effects of the HMG-CoA Reductase Inhibitors in Normal Volunteers and in Patients With Chronic Renal Failure
• Safety and Efficacy Study of BCD-066 Compared to Aranesp® for Anemia Treatment in Chronic Kidney Disease Patients
• Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders
• Eplerenone in Patients Undergoing REnal Transplant (EPURE TRANSPLANT)
• Assessment of Dolutegravir Removed by Hemodialysis in HIV-infected Patients With End-stage Renal Disease
• Safety and Efficacy of Acthar Gel in an Outpatient Dialysis Population
• TRK-100STP PhaseII Clinical Study -Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)
• Helping Olfaction and Nutrition On Renal Replacement
• Study to Evaluate the Safety, Tolerability, Efficacy and PK of IdeS in Kidney Transplantation
• Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients
• Renal Osteodystrophy: An Individual Management Approach
• Multicentre, Open Label, Randomized, Two-arm, Parallel-group Study to Assess Efficacy and Safety of ENVARSUS® Compared With Tacrolimus Used as Per Current Clinical Practice in the Initial Maintenance Setting in de Novo Kidney Transplant Patients
• Once Daily Dosing to Improve Medication Adherence and Patient Satisfaction in Kidney Transplant Recipients
• Multimodal Therapeutic Approach in Undernourished Maintenance Hemodialysis Patients (AMERICANO)
• Phosphodiesterase Type 5 Inhibition to Improve Endothelial Function and Vascular Remodeling in Chronic Kidney Disease and End Stage Renal Disease Patients Requiring New Arteriovenous Fistula
• The Routine Use of SSRI's at the Initiation of End-stage Renal Disease Treatment (RoSIE)
• Ticagrelor and Anti-inflammatory Effects
• Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With Chronic Kidney Diseases Not on Dialysis
• An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Diseas
• Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5
• The Lighthouse Tenofovir Cohort Study
• Quality of Life on Peritoneal Dialysis Versus Hemodialysis in China
• Change From Baseline to Chronic Kidney Disease Patient Before and After Administration Drug
• Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With ERSD Receiving Maintenance Hemodialysis
• A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}
• rESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic Characteristics
• Effectiveness of a Biosimilar Epoetin Alfa in Stable 'End Stage Renal Failure'
• Effect of Ursodeoxycholic Acid on Peritoneal Function in Patients on Peritoneal Dialysis
• Efficacy Study of Zinc Supplementation on Anemia, Oxidative Stress and Inflammation in Hemodialysis Patients
• Determine the Safety/Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis
• Acid-Base Composition With Use of Hemodialysates
• An Open Label, Dose Titration Study of Sevelamer Carbonate Tablets & Powder in Hyperphosphatemic CKD Patients
• A Trial to Investigate the Efficacy and Safety of Orally Administered Tolvaptan (OPC-41061) in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration
• A Randomised Trial Comparing Supraclavicular Block vs Supraclavicular and Pecs II Block in Arteriovenous Grafting
• ESTEROID WITHDRAWAL STUDY, SAFETY AND EFFICACY IN RENAL TRANPLANTATION
• A Study to Evaluate the Pharmacokinetics Of Sativex® in Subjects With Severe Renal Impairment or End Stage Renal Disease, Compared to Matched Subjects With Normal Renal Function.
• Vitamin K Supplementation in Patients on Hemodialysis
• Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)
• Renal Allograft Tolerance Through Mixed Chimerism (Belatacept)
• Pilot PK/PD Study of DS-1093a in Patients With Chronic Kidney Disease
• A Pharmacokinetics, Pharmacodynamics and Safety Study of Single Dose of Rivaroxaban in Participants With End-Stage Renal Disease (ESRD) on Maintenance Hemodialysis
• Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial
• Temocillin Pharmacokinetic in Hemodialysis
• The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure
• Nutrition, Inflammation and Insulin Resistance in End Stage Renal Disease-Aim 2
• Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis
• Study to Evaluate the Efficacy and Safety of Roxadustat in the Treatment of Anemia in Participants With ESRD on Stable Dialysis
• Optimal Anemia Treatment in End Stage Renal Disease (ERSD)
• 16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Subjects With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis
• Study to Assess the Pharmacokinetics of GSK1278863 in Subjects With End Stage Renal Disease Undergoing Peritoneal Dialysis
• Bupropion for Depression in ESRD Patients on Hemodialysis
• Safety and Cardiovascular Efficacy of Hydralazine and Isosorbide Dinitrate in Dialysis-Dependent ESRD
• Bone Mass and Strength After Kidney Transplantation
• Pharmacokinetics of Immunosuppressants in Renal Transplant Candidates Who Have Undergone Laparoscopic Sleeve Gastrectomy
• Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease
• Chinese Medicine on Deferring Dialysis Initiation
• Residual Renal Function Preservation in Peritoneal Dialysis Patients
• Effect of Extraneal (Icodextrin) on Triglyceride Levels in PD Patients
• Effects of Exercise and Improved Nitric Oxide Bioavailability on Arteriovenous Fistula Maturation
• ONSET and OFFSET of Ticagrelor in ESRD
• Pharmacokinetics and Optimal Dose of Ertapenem in Hemodialysis Patients
• Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease
• Trial of Adoptive Immunotherapy With TRACT to Prevent Rejection in Living Donor Kidney Transplant Recipients
• A Study of LY3113593 in Healthy Participants and Participants With Chronic Kidney Disease Treated With Hemodialysis
• A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With End Stage Renal Disease and Healthy Subjects
• C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI
• Belatacept in Kidney Transplantation of Moderately Sensitized Patients
• Boceprevir in End Stage Renal Disease (ESRD)
• Lexaptepid Pegol (NOX-H94) in ESA-hyporesponsive Anemia in Dialysis Patients
• Efficacy of Sodium Polystyrene Sulfonate in the Treatment of Hyperkaliemia in Pre-dialysis Patients
• Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving Dialysis
• Comparison Among Erythropoietin Stimulating Agents
• Dose-finding of Rivaroxaban in Hemodialysis
• The Effect of Daily Tamsulosin 0.2mg Administration on Renal Function in Patients With Benign Prostatic Hyperplasia
• The Desensitization Therapy With GB-0998 for Anti-donor Antibody-positive Recipients.
• Pharmacokinetics, Pharmacodynamics, and Safety Study of Ticagrelor in Hemodialysis Patients and Healthy Subjects
• Evaluating the Effect of Senna in Uremic Pruritus
• Steroid Impregnated Tape in the Treatment of Over-granulating Peritoneal Dialysis Exit Sites
• Two phosphAte taRGets in End-stage Renal Disease Trial (TARGET)
• Gengraf Conversion Study in Stable Renal Allograft Transplant Recipients
• ISCHEMIA-Chronic Kidney Disease Trial
• Pharmacokinetics of an Aminoglycoside in Hemodialysis Patients.
• Effect of Hemodialysis on the PK of JTZ-951 in Subjects With End-stage Renal Disease
• Pharmacokinetics and Safety of Alisporivir in Subjects With End Stage Renal Disease on Hemodialysis Compared to Healthy Subjects
• Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease
• Once-a-day Immunosuppression(CISECON_a_day)
• Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy Wasting
• Does ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED Study
• Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)
• Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal Disease
• Use of Tinzaparin for Anticoagulation in Hemodialysis
• A Study of LY2409021 in Participants With Different Levels of Kidney Function
• Sodium Chloride and Protein-Bound Toxin Removal in Hemodiafiltration
• Different Doses of Oral Melatonin Supplements in Chronic Kidney Disease (CKD)-Associated Sleep Disorders
• A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis
• A Single Ascending Dose Study of Soluble Ferric Pyrophosphate Administered Intravenously in Healthy Volunteers.
• Role of Turmeric on Oxidative Modulation in ESRD Patients
• Post-Marketing Surveillance on Long-Term Drug Use of Kiklin (Bixalomer)® Capsules in Patients With Hyperphosphatemia Receiving Peritoneal Dialysis
• Post-marketing Surveillance of Kiklin Capsules in Hemodialysis Patients
• Open-label Dose-finding Trial of OPC-41061 in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis
• A Study to Investigate the Effect of ASP1517 After Intermittent Oral Dosing in Dialysis Chronic Kidney Disease Patients With Anemia Compared With Darbepoetin as a Reference Drug
• Use Of Fragmin In Hemodialysis
• A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration
• PK of Serelaxin in Severe Renal Impairment and ESRD
• A Comparison of Propofol Based Total Intravenous Anesthesia and Desflurane Based Balanced Anesthesia on Renal Protection During Deceased Brain Dead Donor Kidney Transplantation - A Prospective, Randomized Trial
• Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula
• L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRD
• ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial
• Effects of Dexmedetomidine Premedication on Geriatric Patients With Chronic Renal Failure Undergoing Hip Surgery
• Paricalcitol on Albuminuria, Inflammation and Fibrosis on Proteinuric Chronic Renal Diseases (PALIFE Study)
• Kidney Graft Function Under the Immunosuppression Strategies
• The Use of Furosemide in Patients on Dialysis
• Efficacy and Safety of Sugammadex in Renal Diseased Patients
• Renal Allograft Tolerance Through Mixed Chimerism
• Safety and Effectiveness Evaluation of Two Kinds of Peritoneal Dialysate
• Pharmacodynamic Study of AZD1722 in End-stage Renal Disease Patients on Hemodialysis
• Eculizumab for Prevention and Treatment of Kidney Graft Reperfusion Injury
• The Effect of Balance PD Solution on the Peritoneal Membrane in Patients on Automated Peritoneal Dialysis
• Study to Assess Pegloticase (KRYSTEXXA®) in Patients on Hemodialysis
• The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease
• A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD)
• Pharmacokinetic Profile and Pharmacodynamic Characteristics of a Furosemide High Dosage Formulation in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis
• Efficacy and Safety of Alprostadil Prevent Contrast Induced Nephropathy
• Pharmacokinetics And Dialysability Of CP-690,550 In Subjects With End-Stage Renal Disease
• Qutenza for Critical Ischaemia in End Stage Renal Failure
• Generic Tacrolimus in the Elderly - Prograf® vs Tacni®
• Mineralocorticoid Receptor Antagonists in End Stage Renal Disease
• Effects of Spironolactone on Cardio- and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients
• A Study to Assess the Pharmacokinetics of Ceftaroline in End Stage Renal Disease Patients and Matched Healthy Subjects
• Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
• Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens
• Eplerenone in Hemodialysis Trial
• Hyperglycemia in Renal Transplantation
• The Everolimus-Transplant Exit Strategy Trial (E-TEST)
• RAAS Inhibitor Drugs in Dialysis Patients
• Administration of pH-Neutral Peritoneal Dialysis Solutions Containing Lactate or Bicarbonate in Children
• Renal Transplantation in the Elderly - nEverOld Study
• Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney Disease
• Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 Diabetes
• Study of Everolimus in de Novo Renal Transplant Recipients
• Study of FG-4592 in Subjects With End-Stage Renal Disease Receiving Maintenance Hemodialysis in China
• Sirolimus Use in Angioplasty for Vascular Access Extension
• A Safety Study of Tocilizumab to Improve Transplant Rates in Highly Sensitized Patients Awaiting Kidney Transplantation
• Fosrenol and Phosphorus Balance - Lanthanum Carbonate
• PRevention of End Stage Kidney Disease by Darbepoetin Alfa In Chronic Kidney Disease Patients With nondiabeTic Kidney Disease
• Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction
• A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis
• Pharmacokinetics, Safety and Tolerability of Aliskiren (SPP100) in Patients With End Stage Renal Disease on Hemodialysis and Matched Healthy Subjects
• A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis
• Hydroxychloroquine in Cardiovascular Disease in Patients With Chronic Kidney Disease: A Proof of Concept Study
• A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis
• High Cut-off Hemodialysis in Patients With Advanced Cardiac AL Amyloidosis and End Stage Renal Disease
• Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients
• Mineralocorticoid Receptor Antagonist and Kidney Allograft Histology
• A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal Disease
• Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis
• Desensitization Protocol for Highly Sensitized Patients on the Waiting List for Kidney Transplant
• Pharmacokinetics of Somatropin in Patients With End Stage Renal Disease Receiving Chronic Haemodialysis
• Belatacept in Renal Transplantation With Intermediate Risk Maryland Aggregate Pathology Index (MAPI) Scores
• Safety Study of Renal Function in Patients With Chronic Kidney Failure Taking Lumiracoxib or Diclofenac for Arthralgia
• Prospective Study of End Stage Renal Disease Patients With Coronary Artery Disease Treated by Oral Nicorandil
• A Multi-Center, Open-Label Study
• Clinical Trial on the Use of 25-OH -D Vitamin in Haemodialysis Patients
• Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018)
• Safety and Dialysability of Dotarem® in Dialysed Patients
• Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients
• Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection
• Value Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin D
• Effect of Short Term Aliskiren Treatment in Kidney Transplant Patients
• Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients
• Blood Pressure in Dialysis Patients
• Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients
• Liraglutide Treatment to Patients With Severe Renal Insufficiency
• A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
• Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)
• Exercise Intolerance in Renal Failure
• Low Molecular Weight Heparin for Hemodialysis Anticoagulation
• Safety and Efficacy of the Addition of Alanyl-Glutamine-Dipeptide to Dialysis Solution in Peritoneal Dialysis
• Pharmacokinetics and Pharmacodynamics of Apixaban in Subjects on Hemodialysis
• Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients (CRUISE 2)
• Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients
• Effect of Glucose Degradation Products (GDP) on Endothelial Dysfunction
• Vitamin D3 Supplementation in Dialysis Patients
• Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D
• Effect of Adipokines in Hemodialysis Patients
• Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients
• Use of Telmisartan and Captopril in Inflammation of Hemodialysis Patients
• Pentoxifylline and Systemic Inflammation in Hemodialysis Patients
• Safety Study of TRK-820 for Patient With Hemodialysis
• Study of the Effect of Intradialytic Vasopressin on Chronic Hypertension in Patients With End Stage Renal Disease
• Use of a Bimodal Solution for Peritoneal Dialysis
• Pharmacokinetics of Dabigatran Etexilate (Pradaxa®) During Haemodialysis
• A Study to Evaluate the Effect of Renal Function on the Biological Activity of Telavancin
• Bosutinib In Subjects With Renal Impairment
• Effect of N-acetylcysteine (NAC) on Hydrogen Sulfide (H2S) in Chronic Kidney Disease (CKD)
• Safety and Dose Finding Study of Xigris in Hemodialysis Patients
• Impact of Vitamin D Therapies on Chronic Kidney Disease
• FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney Disease
• Dianeal, Extraneal, Nutrineal (D-E-N) Versus Dianeal Only in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients
• Hemodialysis Vitamin D Pilot
• Nasal Tea Tree Oil for the Prevention of Infections in PD Patients
• Insulin-like Growth Factor (IGF-I) in Hemodialysis Patients
• Studies in Patients With Multiple Myeloma and Renal Failure Due to Myeloma Cast Nephropathy
• Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis
• A Study in Participants With End-Stage Renal Disease
• Aspirin in the Prevention of Cardiovascular Events in Hemodialysis Patients
• A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis
• Efficacy Study of Two Formulations of Erythropoietin
• Impact of Vitamin D Repletion in Hemodialysis Patients
• Effect of Icodextrin Solution on Preservation of Residual Renal Function in Patients on Peritoneal Dialysis
• A Study Comparing the Effects of Epoetin Hospira and Epogen/Epoetin Alfa (Amgen) When Administered IV in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment
• The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney Disease
• Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis
• Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
• Study of FG-4592 in Subjects With End-Stage Renal Disease Receiving Maintenance Hemodialysis
• Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice
• Comparison of the Protective Effect of Desflurane and Propofol in Patients With Renal Transplantation
• Effect of Lanthanum Carbonate in Patients Previously Treated With Calcium-based Phosphate Binder Therapy
• Study of Vitamin C, Vitamin E and Their Combination to Treat Restless Legs Syndrome in Hemodialysis Patients
• MONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disease Stage 5
• Efficacy and Safety of Alfacalcidol Compared to Calcitriol for Treatment of Secondary Hyperparathyroidism
• Study of Erythropoietin (EPO) Administration Schedule
• Anti-Oxidant Effect on Peritoneal Membrane in Peritoneal Dialysis (PD) Patients
• Preventive Effect of the PRetreatment With Intravenous Nicorandil on Contrast-Induced Nephropathy in Patients With RenaL Dysfunction UndEergoing Coronary Angiography (PRINCIPLE Study)
• A Safety Study of Pentoxifylline for the Treatment of Anemia
• Effect of Zinc Suplementation on Serum Hemosystein Level in Hemodialysis Patients
• TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)
• Bioequivalence of a Single Subcutaneous Dose of Epoetin Beta in Healthy Japanese and Caucasian Male Subjects
• A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
• Pharmacokinetics Study of Donepezil HCl in Subjects Receiving Haemodialysis.
• Sevelamer Hydrochloride and Femoral and Carotid Intima Media Thickness Progression in End Stage Renal Disease
• Cost Utility Analysis of Erythropoietin for Anemia Treatment in Hemodialysis Patients
• Thymoglobulin Versus Alemtuzumab Versus Daclizumab in Living Donor Renal Transplantation
• Effect of Turmeric on Pruritus in Hemodialysis Patients
• A Pilot Study to Evaluate ZADAXIN's® (Thymalfasin) Ability to Enhance Immune Response to the H1N1sw Influenza Vaccine
• Pharmacokinetic Study,Ceftobiprole,Healthy Volunteers,Healthy Patients With End Stage Renal Disease
• Eculizumab to Enable Renal Transplantation in Patients With History of Catastrophic Antiphospholipid Antibody Syndrome
• Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients
• Comparative Effects of Milk Thistle Extract With Vitamin-E in Hemodialysis Patients
• Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients
• Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease
• Efficacy and Safety of Everolimus+EC-MPS After Early CNI Elimination vs EC-MPS +Tacrolimus in Renal Transplant Recipients
• Three Times Weekly (TIW) Growth Hormone Therapy in Children on Hemodialysis
• Ertapenem Pharmacokinetics in Patients in Continuous Ambulatory Peritoneal Dialysis
• Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation
• Study to Evaluate the Safety of Chronic Administration of Simulect to Subjects Receiving a First Kidney Transplant
• A Safety Comparison of Iopromide and Iodixanol in Renal Impaired Patients
• L-Carnitine in Peritoneal Dialysis
• Effect of Different Dialysis Dosage on Prognosis in Maintenance Peritoneal Dialysis Patients
• Vitamin D and Arteriovenous Fistulae
• DIVINE: Dialysis Infection and Vitamin D In New England
• Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects
• Study to Evaluate Daptomycin Given During Dialysis and After Dialysis
• Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults
• Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult Volunteers
• Spironolactone and Prevention of Peritoneal Fibrosis in Peritoneal Dialysis
• Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists
• Study of Safety and Efficacy on New Peritoneal Dialysis Solutions
• Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)
• Randomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on Hemodialysis
• Marinobufagenin as a Target for DIGIBIND in Hypertensive Patients With End-stage Renal Disease
• L-Carnitine as an Osmo-metabolic Agent for Peritoneal Dialysis
• Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride
• Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate
• Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD)
• The Clinical Evaluation of the Dose of Erythropoietins Trial
• Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation
• Effects of Phosphate Binding With Sevelamer in Stage 3 Chronic Kidney Disease
• Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection
• Effect of 25-hydroxyvitamin D and a Structured Exercise Program on Dialysis Patients
• Clinical Evaluation of Low Sodium Peritoneal Dialysis (PD) Solution on Hypertensive Patients Treated With PD
• Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)
• Saving Residual Renal Function Among Haemodialysis Patients Receiving Irbesartan
• Panel Reactive Antibody (PRA) Reduction in Sensitized Patients Awaiting Renal Transplantation
• Randomized Multicenter Cross-over Study to Compare the Effect of Physioneal 35 to 40 on the Protein Metabolism
• Safety of Immunosuppression Minimization in Children and Adolescents After Kidney Transplantation
• Effect of an L-carnitine-containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)
• Effect of an L-Carnitine-Containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Diabetic Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)
• Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa.
• Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease Patients
• Sevelamer Hydrochloride in Peritoneal Dialysis Patients
• Peroxisome Proliferator-Activated Receptor-Gamma Activation in Peritoneal Dialysis Patients
• Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus
• Erythropoietin Therapy in Patients With Chronic Renal Failure: A Study of Time Dependent Activity
• Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease
• Study of Inflammation and Oxidative Stress in Persons Undergoing Dialysis
• Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation
• Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure
• Effect of Hydration With Sodium Bicarbonate for Long-Term Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure
• Immune Effects of Vitamin D in Hemodialysis Patients
• Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESA
• Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease
• DELFT (Dynepo Evaluation of Long-Term Follow-Up Treatment)
• Comparisone of Iminoral Versus Neoral in Prevention of Acute Rejection in Renal Transplantation
• A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD)
• A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis
• Pharmacokinetics of Sublingual Versus Oral Tacrolimus in Patients Awaiting Kidney Transplantation
• A Multi-Centered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 (Zuragen) Solution, and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis
• A Novel Catheter Lock Solution for Treatment of Tunneled Hemodialysis Catheter-Associated Bacteremia
• Delivery of Soluble Ferric Pyrophosphate (SFP) Via the Dialysate to Maintain Iron Balance in Hemodialysis Patients
• Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis
• Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis
• Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis
• Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis
• Intradialytic Drug Removal by Short-daily Hemodialysis
• Oral Paricalcitol in Kidney Transplant Recipients
• Intravenous Immune Globulin (IVIG) Treatment Protocol in Kidney Transplant Patients
• Open Label Trial of Fluoxetine for the Treatment of Depression in Patients With End Stage Renal Disease
• Single Dose Pravastatin Pharmacokinetics in Pediatric Peritoneal Dialysis Patients
• Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal Anemia
• Catheters Dysfunction Rate After Instillation of Ethanol 60% Lock Solution in Tunneled Silicone Catheter of Chronic Hemodialysis Patients
• Serum NGAL Levels in Hemodialysis (HD) Patients; Relation to Iron Status, HD and Intravenous (IV) Iron Administration
• Improved Induction and Maintenance Immunosuppression in Kidney Transplantation
• Left Ventricular Hypertrophy and Spironolactone in End Stage Renal Disease
• Dose Ranging Study of Dialysate Containing Soluble Iron to Treat Subjects With End Stage Renal Disease (ESRD) Receiving Chronic Hemodialysis
• Comparison Between Effects of Two Iron Preparations on Protein in the Urine
• Myfortic vs. Cellcept in Kidney Transplant Recipients
• N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure
• Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia
• How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis
• NESP Pediatric Study
• Effects of Mesna on Homocysteine in Kidney Failure
• Dynepo Long-Term Safety Study
• Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)
• Lipid Infusion in Dialysis Patients With Endotoxemia
• The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis
• Vitamin D and Carboxy PTH Fragments in Coronary Calcification
• NAC in Preventing CIN in CRF Patients Who Need Enhanced CT Scan in ED
• Fibrosis in Renal Allografts
• Safety Study to Evaluate Daptomycin in Non-infected Adults Who Are Either on Hemodialysis or Continuous Ambulatory Peritoneal Dialysis (MK-3009-021)
• A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure.
• Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients
• Carbonaceous Oral Adsorbent's Effects on Progression of Chronic Kidney Disease
• Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU)
• Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease (ESRD) Patients
• Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.
• Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant
• Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia
• Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis
• A Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD)
• Inhibition of Aldosterone in Patients With Chronic Renal Disease
• A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole
• Inflammation, Proteolysis and IL-1 Beta Receptor Inhibition in Chronic Hemodialysis Patients
• Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
• A Study of NeoRecormon (Epoetin Beta) in Patients With End Stage Renal Disease.
• Oxidative Stress and Hemodialysis Access Failure
• Use of Ointments in Prevention of Catheter Related Infections in PD
• Efficacy & Safety Study of Recombinant Human Erythropoietin -Alpha, in Patients With Anemia of Chronic Renal Failure
• Improved Estimation of GFR by Cystatin C in Preventing Contrast Induced Nephropathy by NAC or Zn
• Growth Hormone Secretagogue MK-0677 Effect on IGF-1 Levels in ESRD Patients
• Glycyrrhetinic Acid-Effect on Serum Potassium and Insulin Resistance in Dialysis Patients
• Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients
• A Phase II, Randomized, Cross-Over, Vehicle-Controlled, Double-Blind, Multicenter Study of the Safety, Pharmacodynamics, and Preliminary Efficacy of GHRP-1/AG in Subjects With ESRD on Hemodialysis
• ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
• Study of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid Withdrawal
• Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD
• Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria
• An Evaluation of the Long-term Safety of Magnesium Iron Hydroxycarbonate
• Effect of Two Iron Preparations on Protein in the Urine
• EPO-BUL-01 - Study of the Optimization of Anemia Management of EPREX (Epoetin Alfa) in Predialysis Patients With Chronic Renal Failure
• A Study of the Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-term Care Facilities.
• Renal Transplantation and Inhaled Anesthetic Sevoflurane (SEVOREIN)
• Spironolactone Safety in Dialysis Patients
• Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial
• REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm Trial
• Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients
• Uremic Hyperhomocysteinemia -A Folate Trial for Possible Prevention of Cardiovascular Events
• Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney Disease
• Effects of Early Correction of Anemia in Patients With Chronic Renal Insufficiency
• Changes in Iron Markers Following Iron Loading in Hemodialysis Patients
• A Pilot Study of Fish Oil Supplementation in Hemodialysis Patients
• The Effect of CoQ10 Administration on Hemodialysis Patients
• Case-Control Study on Analgesics and Nephropathy (SAN)
• Desensitization of Renal Transplant Candidates
• Efficacy of Intravenous Iron Administration in Hemodialysis Patients
• Effects of Lowering Dialysate Calcium Level on Progression of Coronary Artery Calcification and Bone Histomorphometry
• Safety and Efficacy Study of the Effect of Etanercept in Hemodialysis Patients
• Simvastatin Effect on End Stage Renal Failure Patients Treated by Peritoneal Dialysis
• Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
• Pentoxifylline and Progression of Chronic Kidney Disease in Moderate-to-high Risk Patients
• Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch
• Benazepril for Advanced Chronic Renal Insufficiency
• Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on Hemodialysis
• Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
• Can Alendronate Suppress Calcification and Improve Bone Density in Chronic Peritoneal Dialysis Patients?
• A Study of the Safety and Efficacy of Long-term Correction of Anemia With Epoetin Alfa in Early Hemodialysis Patients
• Intravenous n-3 Fatty Acids and Sudden Cardiac Death in Hemodialysis Patients
• Omacor in Prevention of Cardiovascular Events in Patients Undergoing Chronic Hemodialysis
• Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
• Anabolic Steroids and Exercise in Hemodialysis Patients
• The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients
• Prophylactic Effect of Nifedipine on Further Decline in Renal Function in Patients Undergoing Open-Heart Surgery
• Effects of Nutritional Supplementation on Protein and Energy Homeostasis in Malnourished Chronic Hemodialysis Patients
• Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients
• AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD)
• Cohort Study to Determine the Long-Term Safety and Efficacy of Biogeneric Epoetin Treatment for Renal Anemia
• Provision of Antioxidant Therapy in Hemodialysis (PATH) Study
• Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia
• Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis
• Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease
• Efficacy and Safety Study of GerEPO
• Peginesatide for Anemia in Chronic Hemodialysis Patients
• Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients
• DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
• Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients
• Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents
• Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients
• A Study to Evaluate the Efficacy and Safety of an Experimental Solution for Peritoneal Dialysis
• A Subjective Evaluation of Inflow Pain Associated With the Use of an Experimental Solution for Peritoneal Dialysis
• Darbepoetin Treatment of Anemia in Children With Chronic Renal Failure
• A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring IGF-1 Levels in Blood
• Intravenous Iron in Patients With Anemia of Chronic Kidney Disease
• MMF and Calcineurin Inhibitor Withdrawal in CAN
• Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans
• Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease
• The Vienna Prograf and Endothelial Progenitor Cell Study
• The Effects of Resistance Exercise and Protein Supplementation in Hemodialysis Patients
• Complementary Intradialytic Nutritional Supplementation in Dialysis Patients
• The Effects of Nutrition Supplementation and Resistance Exercise During Hemodialysis
• The Effects of Protein Supplementation and Resistance Exercise in Hemodialysis Patients
• Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients
• Prevention of Contrast-Induced Nephropathy
• Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal Disease
• Can Intravenous Vitamin C Improve Skin Hyperpigmentation in Long-Term Hemodialysis Patients?
• Comparison of Oxidative Stress and Insulin Resistance Before and After Using Physioneal in Peritoneal Dialysis Patients
• Rituximab Desensitization Therapy for Patients on the Waiting List for Kidney Transplant
• Genetic Determinants of the Hypokalemic and Hyperglycemic Effect of Albuterol Inhalation
• Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease
• Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters
• Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving Dialysis
• Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease
• Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection
• Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their Blood
• A Long Term Study of Lanthanum Carbonate in Patients Requiring Dialysis Who Have Ived Lanthanum Carbonate in Previous Studies Defined by the Protocol.
• Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers
• Sodium-Endothelial Function-CKD Study
• Haemodialysis Salt Reduction Study
• ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial
• Effects of Cyclosporine A on Pancreatic Insulin Secretion
• Influence of Amlodipine on the Mortality of Patients With End-Stage Renal Failure
• An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery
• To Determine the Effects of Avosentan on Doubling of Serum Creatinine, End Stage Renal Disease and Death in Diabetic Nephropathy
• Evaluating Aranesp® in Subjects With End Stage Renal Disease onChronic Hemodialysis
• SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism
• Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) Levels
• Research Study Evaluating Cinacalcet for Patients With End Stage Renal Disease (ESRD)
• Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis
• Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)
• A Research Study for Patients With End-Stage Renal Disease (ESRD)
• Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease
• Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy
• Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers
• Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis
• Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis
• A Clinical Study to Assess the Safety of PEG-Hirudin (SPP200) Compared to Heparin in Patients Who Are on Haemodialysis
• Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant
• Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis
• Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on Hemodialysis
• Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients
• A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis
• A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients
• Pharmacokinetics/Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease Patients Undergoing Hemodialysis
• Homocysteine Study (HOST)
• Isoflavones and Acute-phase Response in Chronic Renal Failure
• Steroid Withdrawal in Pediatric Kidney Transplant Recipients
• Pediatric Kidney Transplant Without Calcineurin Inhibitors
• Kidney Transplant for HIV-Infected Patients in Renal Failure
• A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant
• Prevention of Kidney Transplant Rejection
• Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis
• Randomized Study of Recombinant Human Growth Hormone in Patients on Chronic Hemodialysis or Peritoneal Dialysis
• Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance Dialysis
• Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure